A NEW POSSIBILITY FOR PHYSIQUE MANAGEMENT ?

Experts are excitedly focused on retatrutide, a novel medication created by Eli Lilly, as a possible breakthrough in physique management. Distinct from many existing approaches, retatrutide is a dual -action agonist targeting both GLP-1 and GIP, hormones that impact satiety and blood glucose bal